Komtur Pharmaceuticals Iberia
Komtur Pharmaceuticals Iberia is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase II, multi-site, open-label, dose-titration trial to investigate the safety, tolerability, pharmacokinetics, and efficacy of Lu AG13909 in adults with Cushing’s disease
Sponsor H. Lundbeck A/S
- Start (EU)
- Latest update
- Estimated end
A Double-Blind, Randomized, Placebo and Active Controlled Study to Evaluate the Efficacy and Safety of Once Daily, Extended Release Levetiracetam as Add-on Therapy in Patients with Refractory Partial Onset Epilepsy.
Sponsor Neuraxpharm Pharmaceuticals S.L.
- Start (EU)
- Latest update
- Estimated end
A Prospective, Open-Label, Randomized, Interventional Study to Evaluate the Efficacy and Tolerability of Sucrosomial® Iron vs Ferric Maltol in Iron Deficient Women
Sponsor Pharmanutra S.p.A.
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Komtur Pharmaceuticals Iberia?
The 2026-10-09 snapshot links Komtur Pharmaceuticals Iberia to 3 distinct CTIS trials. Recorded services include Medicinal product management, Sourcing and importing comparator pharmaceutical products. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Komtur Pharmaceuticals Iberia?
The most frequently recorded therapeutic areas are Endocrinology, Neurology. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Komtur Pharmaceuticals Iberia conducted?
The linked trials record locations in 10 countries, including Spain, Hungary, Italy, Poland, Romania. These are trial locations, not confirmed office locations or countries where Komtur Pharmaceuticals Iberia delivered services.
What can this page tell me about Komtur Pharmaceuticals Iberia's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Komtur Pharmaceuticals Iberia. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Komtur Pharmaceuticals Iberia S.L.